10x Genomics, Inc.

SEC 8-K · Filed

0001770787-24-000007Accepted

Applies to the EDGAR acceptance time.

Other time zone
Leadership changesItem 5.02Effective date Feb 1, 2024

James Wilbur — announced departure from the Chief Commercial Officer role

Dr. Wilbur will depart the Company on February 1, 2024
Structured facts
{
  "action": "departed",
  "evidence": "Dr. Wilbur will depart the Company on February 1, 2024",
  "identity_source": "https://www.sec.gov/Archives/edgar/data/1770787/000161071723000367/0001610717-23-000367-index.htm",
  "person": "James Wilbur",
  "person_cik": "0001940931",
  "role": "Chief Commercial Officer",
  "state": "announced"
}